Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
10
Number of overlapping holdings
40.0%
% of BBH's 27 holdings also in CANC
21.3%
% of CANC's 47 holdings also in BBH
Overlap by Weight
Sector Drift (BBH minus CANC)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BBH |
Weight in CANC |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 10.8% | 5.4% | 5.4% |
|
REGENERON PHARMACEUTICALS | 6.5% | 5.4% | 5.4% |
 |
ARGENX SE ADR | 5.5% | 4.3% | 4.3% |
|
ILLUMINA INC | 4.3% | 3.8% | 3.8% |
|
BEIGENE LTD. SPONSORED ADR | 2.0% | 2.5% | 2.0% |
Position Highlights (Non-Overlapping Exposures)
BBH Overweight Relative to CANC
|
AMGEN INC | 14.2% |
|
VERTEX PHARMACEUTICALS INC | 10.6% |
|
GILEAD SCIENCES INC | 5.3% |
|
IQVIA HOLDINGS INC | 4.5% |
|
NATERA INC | 3.9% |
|
BIOGEN IDEC INC | 3.7% |
 |
ICON PLC | 3.5% |
|
ALNYLAM PHARMACEUTICALS INC | 3.4% |
|
NEUROCRINE BIOSCIENCES INC | 2.3% |
|
INSMED INC | 2.2% |
BBH Underweight Relative to CANC
 |
ASTRAZENECA PLC | -5.2% |
|
REVOLUTION MEDICINES, INC. | -4.6% |
|
BLUEPRINT MEDICINES CORP. | -4.3% |
 |
CHUGAI PHARMACEUTICAL CO LTD | -3.3% |
|
DAIICHI SANKYO CO LTD | -3.1% |
|
EXELIXIS INC | -3.0% |
|
MERCK & CO. INC. | -2.9% |
|
AGIOS PHARMACEUTICALS INC | -2.9% |
|
INCYTE CORP | -2.6% |
|
CRISPR THERAPEUTICS AG | -2.5% |